查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1895152

藥品批發和分銷市場：2025-2035

Pharma Wholesale and Distribution Market Report 2025-2035
出版日期: | 出版商: Visiongain | 英文 303 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2035年，全球藥品批發和分銷市場將以7.8%的複合年增長率成長。

冷鍊是特種藥品成長的核心：

藥品批發和分銷行業正在經歷一場決定性的結構性變革。冷鏈不再是次要的物流環節，而是已成為該產業的核心策略基礎。隨著疫苗、生物製劑、細胞和基因療法以及快速增長的GLP-1類藥物等對溫度敏感的產品在全球產品線中所佔比例不斷增加，批發商和分銷商正在重新構想他們的戰略，以滿足對冷凍和冷藏存儲、經過驗證的包裝系統以及大規模連續溫度完整性監測日益增長的需求。

這一轉變體現在2025年的兩項重大公告中，這兩項公告標誌著基礎設施現代化進入了一個新階段。 2025年3月，DHL宣布達成協議，收購美國生命科學物流專家CryoPDP，以增強其在生物製藥、先進療法和臨床試驗配送領域的溫控能力。該公司2024年醫療保健業務收入達57億美元，此舉凸顯了其致力於透過整合端到端平台引領全球冷鏈物流的決心。 2025年11月5日，Cencora宣布了一項突破性的10億美元投資計劃，旨在到2030年改造其美國藥品配送網絡。該計畫包括在俄亥俄州哈里森新建一座53萬平方英尺的全國配送中心，以及在加州和阿拉巴馬州進行大規模擴建。這些新一代配送中心將整合先進的倉庫自動化系統、機器人揀選系統以及顯著提升的冷藏和冷凍儲存能力，以支援日益增長的特殊藥品配送需求。

這些發展標誌著醫藥批發和分銷生態系統的重要轉折點。成長最快的治療領域——腫瘤藥物、生物製劑、疫苗和GLP-1療法——需要高度可靠的冷鏈管理和精準處理。 Cencora的投資重新定義了競爭優勢。批發商現在必須成為冷鏈、自動化和數據驅動型物流專家，而不僅僅是供應鏈中間商。

從品牌藥和仿製藥分銷商到疫苗、生物製藥和醫療器材管道，所有細分市場都受到了影響。與高性能溫控物流合作夥伴進行策略合作，或發展同等程度的內部能力，正成為獲得全國性合約、機構投標和與製造商建立長期合作關係的先決條件。

隨著冷鏈逐漸成為關鍵資產，市場領導者將憑藉其在日益複雜的產品組合中提供溫控完整性、營運韌性和技術賦能的卓越分銷能力而脫穎而出。

本報告分析了全球藥品批發和分銷市場，並提供了市場概覽、市場成長因素和市場機會分析、市場規模趨勢和預測、按細分市場、地區和主要國家/地區進行的詳細分析、競爭格局以及主要公司簡介。

目錄

第一章：報告概述

第二章：摘要整理

第三章：市場概覽

  • 主要發現
  • 市場動態
    • 市場驅動因素
    • 市場限制因素
    • 市場機遇
  • 美國關稅：對全球藥品批發和分銷市場的影響
  • 波特五力分析
  • PEST分析

第四章 藥品批發和分銷市場分析：按類型劃分

  • 主要發現
  • 市場吸引力指數
  • 市場規模估算與預測
  • 批發商
    • 按地區劃分的市場規模
    • 按地區劃分的市場佔有率
    • 按類型劃分的市場規模
    • 生產商批發商
    • 商業批發商
    • 代理商和經紀人
  • 經銷商
    • 按地區劃分的市場規模
    • 按地區劃分的市場佔有率
    • 按類型劃分的市場規模
    • 單一經銷商
    • 多方經銷商

第五章 藥品批發及分銷市場分析：依分銷類型劃分

  • 主要發現
  • 市場吸引力指數
  • 市場規模估算與預測
  • 品牌藥/處方藥分銷商
  • 仿製藥經銷商
  • PCD特許經營
  • 非處方藥/機構供應藥品分銷商
  • 其他
    • 市場規模趨勢與預測：按地區劃分
    • 市佔率歷史資料與預測：按地區劃分

第六章 藥品批發及分銷市場分析：依產品類型劃分

  • 主要發現
  • 市場吸引力指數
  • 市場規模估算與預測
  • 品牌藥
  • 仿製藥
  • 非處方藥
  • 醫療器材
  • 疫苗
  • 其他
    • 市場規模趨勢與預測：按地區劃分
    • 市佔率表現與預測：按地區劃分

第七章：藥品批發和分銷市場分析：按最終用戶

  • 主要發現
  • 市場吸引力指數
  • 市場規模估算與預測
  • 醫院和診所
  • 零售藥局
  • 線上藥局
  • 其他
    • 市場規模趨勢與預測：按地區劃分
    • 市佔率表現與預測：按地區劃分

第八章：藥品批發和分銷市場分析：按地區劃分

  • 主要發現
  • 市場規模趨勢與預測：按地區劃分

第九章：北美藥品批發和分銷市場分析

  • 主要發現
  • 市場吸引力指數
  • 各國市場規模：2025年、2030年2035
  • 市場規模估計與預測：依國家劃分
  • 市場規模估算與預測：依類型劃分
  • 市場規模估算與預測：依分銷類型劃分
  • 市場規模估算與預測：依產品類型劃分
  • 市場規模估算與預測：依最終用戶劃分
  • 美國
  • 加拿大

第十章 歐洲藥品批發與配銷市場分析

  • 主要發現
  • 市場吸引力指數
  • 依國家劃分的市場規模：2025年、2030年、2035年
  • 市場估計與預測：依國家劃分
  • 市場估計與預測：依類型劃分
  • 市場估計與預測：依分銷類型劃分
  • 市場估算與預測：依產品類型劃分類型
  • 市場估計與預測：依最終用戶劃分
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他

第十一章 亞太地區藥品批發與分銷市場分析

  • 主要發現
  • 市場吸引力指數
  • 各國市場規模：2025年、2030年、2035年
  • 市場估計與預測：依國家劃分
  • 市場估計與預測：依類型劃分
  • 市場估計與預測：依分銷類型劃分
  • 市場估算與預測：依產品類型劃分
  • 市場估計與預測：依最終用戶劃分用戶
  • 日本
  • 中國
  • 印度
  • 澳大利亞
  • 韓國
  • 東南亞
  • 其他

第十二章 拉丁美洲藥品批發及配銷市場分析

  • 主要發現
  • 市場吸引力指數
  • 依國家劃分的市場規模：2025年、2030年、2035年
  • 按國家/地區劃分的市場估計和預測
  • 按類型劃分的市場估算與預測
  • 按分銷類型劃分的市場估算與預測
  • 依產品類型劃分的市場估算與預測
  • 按最終用戶劃分的市場估算與預測用戶
  • 巴西
  • 墨西哥
  • 阿根廷
  • 哥倫比亞
  • 其他

第十三章 中東及非洲藥品批發及配銷市場分析

  • 主要發現
  • 市場吸引力指數
  • 依國家劃分的市場規模：2025年、2030年、2035年
  • 按國家/地區劃分的市場估計和預測
  • 按類型劃分的市場估算與預測
  • 按分銷類型劃分的市場估算與預測
  • 依產品類型劃分的市場估算與預測
  • 按最終用戶劃分的市場估算和預測
  • 海灣合作委員會國家
  • 南非
  • 其他

第十四章：公司簡介

  • Cencora,公司
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.

第十五章 結論與建議

  • Visiongain 的結論
  • 對參與者的建議
Product Code: PHA1377

The global Pharma Wholesale and Distribution market is projected to grow at a CAGR of 7.8% by 2035.

The Pharma Wholesale and Distribution Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Cold Chain Positions Itself as the Core of Specialty Pharma Growth

The pharmaceutical wholesale and distribution landscape is undergoing a decisive structural shift: cold chain is no longer a supportive logistics layerit has become the industry's core strategic backbone. With an expanding share of global pipelines centred on temperature-sensitive productsincluding vaccines, biologics, cell- and gene-based therapies, and the accelerating GLP-1 classwholesalers and distributors are realigning their strategies according to the growing demand for frozen and refrigerated storage, validated packaging systems, and continuous temperature-integrity monitoring at scale.

This shift is reflected in two major 2025 announcements signalling a new phase of infrastructure modernisation. In March 2025, DHL confirmed its agreement to acquire U.S. life-science logistics specialist CryoPDP, strengthening its temperature-controlled capabilities across biopharma, advanced therapies and clinical-trial distribution. The move builds on the company's US$5.7 billion healthcare revenues in 2024, underscoring its ambition to lead global cold-chain logistics through integrated, end-to-end platforms.

On 5 November 2025, Cencora unveiled a landmark US$1 billion investment programme aimed at transforming its U.S. pharmaceutical distribution network through 2030. The initiative includes construction of a new 530,000 sq. ft national distribution centre in Harrison, Ohio, alongside major expansions in California and Alabama. These next-generation hubs will integrate advanced warehouse automation, robotic picking systems and significantly enhanced refrigerated and frozen storage capacity to support the rising flow of specialty pharmaceuticals.

For the pharma wholesale and distribution ecosystem, these developments mark a critical inflection point. The fastest-expanding therapeutic categoriesoncology drugs, biologics, vaccines, and GLP-1 therapiesdemand ultra-reliable cold-chain control and precision handling. Cencora's investment signals a recalibration of competitive advantage: wholesalers must now operate as cold-chain, automation and data-driven fulfilment specialists, not merely intermediaries in the supply chain.

The implications are clear for all players across your segmentationfrom branded and generic pharmaceutical distributors to vaccine, biologics, and medical-device channels. Strategic alignment with high-performance temperature-controlled logistics partnersor the development of internal capabilities of comparable scaleis rapidly becoming a prerequisite to securing national contracts, institutional tenders and long-term manufacturer partnerships.

As cold chain transitions into a mission-critical asset, market leaders will be defined by their ability to deliver temperature-integrity, operational resilience and technology-enabled distribution excellence across increasingly complex product portfolios.

What would be the Impact of US Trade Tariffs on the Global Pharma Wholesale and Distribution Market?

U.S. trade tariffs can significantly disrupt global pharmaceutical wholesale and distribution by increasing import costs for APIs, finished drugs, packaging materials and medical devices sourced from China, India and Europe. Higher landed costs compress distributor margins and may trigger price adjustments across branded, generic and OTC channels. Tariffs also slow cross-border flow times, forcing wholesalers to hold larger safety stocks and invest more in working capital. For multi-party distributors and PCD/institutional suppliers, tariff volatility increases procurement risk and complicates contracting with manufacturers. Ultimately, tariffs create cost instability, supply uncertainty and operational pressure across the entire distribution ecosystem.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Pharma Wholesale and Distribution market evolving?
  • What is driving and restraining the Pharma Wholesale and Distribution market?
  • How will each Pharma Wholesale and Distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each Pharma Wholesale and Distribution submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading Pharma Wholesale and Distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Pharma Wholesale and Distribution projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of
  • Pharma Wholesale and Distribution projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Pharma Wholesale and Distribution market?
  • Where is the Pharma Wholesale and Distribution market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pharma Wholesale and Distribution market today, and over the next 10 years:

  • Visiongain's 303-page report provides 112 tables and 158 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

  • Type
  • Wholesalers
  • Producer Wholesaler
  • Merchant Wholesaler
  • Agents and Brokers
  • Distributor
  • Single Party Distributor
  • Multi Party Distributor
  • Distribution Type
  • Ethical/Branded Pharma Products Distributors
  • Generic Pharma Products Distributors
  • Propaganda Cum Distribution (PCD) Franchise
  • OTC/Institutional Supply Pharma Distributors
  • Others
  • Product Type
  • Branded Pharmaceuticals
  • Generic Pharmaceuticals
  • Over-the-counter (OTC) Pharmaceuticals
  • Vaccines
  • Medical Devices
  • Others
  • End-users
  • Hospitals & Clinics
  • Retail Pharmacies
  • Online / E-Pharmacies
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles for some of the leading companies in the Pharma Wholesale and Distribution Market, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies and the potential for market growth
  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.

Overall world revenue for Pharma Wholesale and Distribution Market, 2025 to 2035 in terms of value the market will surpass US$ 1,033.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Pharma Wholesale and Distribution Market, 2025 to 2035 report help you?
  • In summary, our 300+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Pharma Wholesale and Distribution Market 2025 to 2035, with forecasts for type, distribution type, product type, and end-users, each forecast at a global and regional level discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 24 key national markets See forecasts for the Pharma Wholesale and Distribution Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market including company profiles for 15 of the major companies involved in the Pharma Wholesale and Distribution Market, 2025 to 2035.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Pharma Wholesale and Distribution Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Demand for Prescription and OTC Drugs
      • 3.2.1.2 Healthcare Infrastructure Expansion
      • 3.2.1.3 Regulatory Compliance and Safety Requirements
      • 3.2.1.4 Shift Towards Specialty Drugs and Biologics
      • 3.2.1.5 Growing Global Pharmaceutical Sales
      • 3.2.1.6 Rising Seaborne Pharmaceutical Transportation
      • 3.2.1.7 Automation and Digitalization Driving Industry Growth
      • 3.2.1.8 Implementation of Track and Trace Solutions
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Stringent Regulations Imposed by Government
      • 3.2.2.2 Price Pressures Likely to Challenge Market Growth
      • 3.2.2.3 Rise in Pharmaceutical Counterfeiting
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Specializing in Niche Drugs and Therapies
      • 3.2.3.2 Embracing E-commerce and Digital Technologies
      • 3.2.3.3 Focusing on Sustainability and Ethical Sourcing
      • 3.2.3.4 Implementation of AI in Pharmaceutical Supply Chain
  • 3.3 U.S. Tariffs: What's the Impact on Global Pharma Wholesale and Distribution Market?
    • 3.3.1 Overview
    • 3.3.2 V-Shaped Recovery Scenario
    • 3.3.3 Why V-Shaped Recovery?
      • 3.3.3.1 Impact from Tariffs
      • 3.3.3.2 Market Dynamics and Demand Recovery
      • 3.3.3.3 Policy and Funding Support
      • 3.3.3.4 Timeframe for Recovery
    • 3.3.4 U-Shaped Recovery Scenario
      • 3.3.4.1 Why U-Shaped Recovery?
      • 3.3.4.2 Impact from Tariffs
      • 3.3.4.3 Market Dynamics and Demand Recovery
      • 3.3.4.4 Policy and Funding Support
      • 3.3.4.5 Timeframe for Recovery
    • 3.3.5 L Shaped Recovery Scenario
      • 3.3.5.1 Why L-Shaped Recovery?
      • 3.3.5.2 Impact from Tariffs
      • 3.3.5.3 Market Dynamics and Demand Recovery
      • 3.3.5.4 Policy and Funding Support
      • 3.3.5.5 Timeframe for Recovery
    • 3.3.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.3.7 Impact of U.S. and China Trade War on Pharma Wholesale and Distribution Market
    • 3.3.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Pharma Wholesale and Distribution Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 4.4 Wholesalers
    • 4.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.4.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.3 Market Size by Type, 2025-2035 (US$ Billion)
    • 4.4.4 Producer Wholesaler
    • 4.4.5 Merchant Wholesaler
    • 4.4.6 Agents and Brokers
  • 4.5 Distributor
    • 4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.3 Market Size by Type, 2025-2035 (US$ Billion)
    • 4.5.4 Single Party Distributor
    • 4.5.5 Multi Party Distributor

5 Pharma Wholesale and Distribution Market Analysis by Distribution Type

  • 5.1 Key Findings
  • 5.2 Distribution Type Segment: Market Attractiveness Index
  • 5.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 5.4 Ethical/Branded Pharma Products Distributors
    • 5.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Generic Pharma Products Distributors
    • 5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Propaganda Cum Distribution (PCD) Franchise
    • 5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 OTC/Institutional Supply Pharma Distributors
    • 5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)

6 Pharma Wholesale and Distribution Market Analysis by Product Type

  • 6.1 Key Findings
  • 6.2 Product Type Segment: Market Attractiveness Index
  • 6.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 6.4 Branded Pharmaceuticals
    • 6.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Generic Pharmaceuticals
    • 6.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)
  • 6.6 Over-the-counter (OTC) Pharmaceuticals
    • 6.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.6.2 Market Share by Region, 2025 & 2035 (%)
  • 6.7 Medical Devices
    • 6.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.7.2 Market Share by Region, 2025 & 2035 (%)
  • 6.8 Vaccines
    • 6.8.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.8.2 Market Share by Region, 2025 & 2035 (%)
  • 6.9 Others
    • 6.9.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.9.2 Market Share by Region, 2025 & 2035 (%)

7 Pharma Wholesale and Distribution Market Analysis by End-users

  • 7.1 Key Findings
  • 7.2 End-users Segment: Market Attractiveness Index
  • 7.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 7.4 Hospitals and Clinics
    • 7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.4.2 Market Share by Region, 2025 & 2035 (%)
  • 7.5 Retail Pharmacies
    • 7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.5.2 Market Share by Region, 2025 & 2035 (%)
  • 7.6 Online / E-Pharmacies
    • 7.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.6.2 Market Share by Region, 2025 & 2035 (%)
  • 7.7 Others
    • 7.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Pharma Wholesale and Distribution Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Pharma Wholesale and Distribution Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Pharma Wholesale and Distribution Market Attractiveness Index
  • 9.3 North America Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 9.4 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 9.5 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 9.6 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 9.7 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 9.8 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 9.9 U.S. Pharma Wholesale and Distribution Market Analysis
  • 9.10 Canada Pharma Wholesale and Distribution Market Analysis

10 Europe Pharma Wholesale and Distribution Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Pharma Wholesale and Distribution Market Attractiveness Index
  • 10.3 Europe Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 10.4 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 10.5 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 10.6 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 10.7 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 10.8 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 10.9 Germany Pharma Wholesale and Distribution Market Analysis
  • 10.10 France Pharma Wholesale and Distribution Market Analysis
  • 10.11 UK Pharma Wholesale and Distribution Market Analysis
  • 10.12 Italy Pharma Wholesale and Distribution Market Analysis
  • 10.13 Spain Pharma Wholesale and Distribution Market Analysis
  • 10.14 Russia Pharma Wholesale and Distribution Market Analysis
  • 10.15 Rest of Europe Pharma Wholesale and Distribution Market Analysis

11 Asia Pacific Pharma Wholesale and Distribution Market analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
  • 11.3 Asia Pacific Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 11.4 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 11.6 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 11.7 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 11.8 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 11.9 Japan Pharma Wholesale and Distribution Market Analysis
  • 11.10 China Pharma Wholesale and Distribution Market Analysis
  • 11.11 India Pharma Wholesale and Distribution Market Analysis
  • 11.12 Australia Pharma Wholesale and Distribution Market Analysis
  • 11.13 South Korea Pharma Wholesale and Distribution Market Analysis
  • 11.14 South-East Asia Pharma Wholesale and Distribution Market Analysis
  • 11.15 Rest of Asia Pacific Pharma Wholesale and Distribution Market Analysis

12 Latin America Pharma Wholesale and Distribution Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
  • 12.3 Latin America Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 12.4 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 12.5 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 12.6 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 12.7 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 12.8 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 12.9 Brazil Pharma Wholesale and Distribution Market Analysis
  • 12.10 Mexico Pharma Wholesale and Distribution Market Analysis
  • 12.11 Argentina Pharma Wholesale and Distribution Market Analysis
  • 12.12 Colombia Pharma Wholesale and Distribution Market Analysis
  • 12.13 Rest of Latin America Pharma Wholesale and Distribution Market Analysis

13 MEA Pharma Wholesale and Distribution Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Pharma Wholesale and Distribution Market Attractiveness Index
  • 13.3 MEA Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 13.4 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
  • 13.5 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
  • 13.6 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
  • 13.7 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
  • 13.8 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
  • 13.9 GCC Pharma Wholesale and Distribution Market Analysis
  • 13.10 South Africa Pharma Wholesale and Distribution Market Analysis
  • 13.11 Rest of MEA Pharma Wholesale and Distribution Market Analysis

14 Company Profiles

  • 14.1 Cencora, Inc.
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis
      • 14.1.3.1 Net Revenue, 2020-2024
      • 14.1.3.2 Regional Market Shares, 2024
    • 14.1.4 Service Benchmarking
    • 14.1.5 Strategic Outlook
  • 14.2 Cardinal Health, Inc.
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2020-2024
      • 14.2.3.2 Regional Market Shares, 2024
    • 14.2.4 Service Benchmarking
    • 14.2.5 Strategic Outlook
  • 14.3 CuraScript, Inc.
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Service Benchmarking
  • 14.4 Dakota Drug, Inc.
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Service Benchmarking
  • 14.5 Fortissa
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Service Benchmarking
  • 14.6 Geo-Young Co., Ltd.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Service Benchmarking
  • 14.7 Kingworld Medicines Group Limited
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Service Benchmarking
  • 14.8 Mckesson Corporation
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2020-2024
      • 14.8.3.2 Regional Market Shares, 2024
    • 14.8.4 Service Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 Medipal Holdings Corporation
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2017-2022
    • 14.9.4 Service Benchmarking
  • 14.10 Mutual Drug
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Service Benchmarking
  • 14.11 Petrone Group
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Service Benchmarking
    • 14.11.4 Strategic Outlook
  • 14.12 Prodigy Health LLC
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Service Benchmarking
  • 14.13 Sinopharm Group Co. Ltd.
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2017-2022
    • 14.13.4 Service Benchmarking
  • 14.14 Smith Drug Co., Inc.
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Service Benchmarking
  • 14.15 Walgreens Boots Alliance, Inc.
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2017-2022
    • 14.15.4 Service Benchmarking
    • 14.15.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Pharma Wholesale and Distribution Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
  • Table 2 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 5 Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 6 Wholesalers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 7 Wholesaler Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 8 Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 9 Distributor Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 10 Pharma Wholesale and Distribution Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 11 Ethical/Branded Pharma Product Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 12 Generic Pharma Product Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 13 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 14 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 16 Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 17 Branded Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 18 Generic Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 19 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 20 Medical Devices Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 21 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 22 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 23 Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 24 Hospitals & Clinics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 25 Retail Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 26 Online / E-Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 27 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 28 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 29 North America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 30 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 31 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 32 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 33 North America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 34 U.S. Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 35 Canada Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 36 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 37 Europe Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 38 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 39 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 40 Europe Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 41 Germany Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 42 France Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 43 UK Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 44 Italy Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 45 Spain Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 46 Russia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 47 Rest of Europe Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 48 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 49 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 50 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 51 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 52 Asia Pacific Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 53 Japan Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 54 China Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 55 India Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 56 Australia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 57 South Korea Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 58 South-East Asia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 59 Rest of Asia Pacific Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 60 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 61 Latin America Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 62 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 63 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 64 Latin America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 65 Brazil Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 66 Mexico Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 67 Argentina Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 68 Colombia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 69 Rest of Latin America Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 70 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 71 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 72 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 73 MEA Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 74 MEA Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 75 GCC Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 76 South Africa Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 77 Rest of MEA Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
  • Table 78 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Cencora, Inc.: Service Benchmarking
  • Table 80 Cencora, Inc.: Strategic Outlook
  • Table 81 Cardinal Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Cardinal Health, Inc.: Service Benchmarking
  • Table 83 Cardinal Health, Inc.: Strategic Outlook
  • Table 84 CuraScript, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 CuraScript, Inc.: Service Benchmarking
  • Table 86 Dakota Drug, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 Dakota Drug, Inc.: Service Benchmarking
  • Table 88 Fortissa: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Fortissa: Service Benchmarking
  • Table 90 Geo-Young Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Geo-Young Co., Ltd.: Service Benchmarking
  • Table 92 Kingworld Medicines Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Kingworld Medicines Group Limited: Service Benchmarking
  • Table 94 Mckesson Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Mckesson Corporation: Service Benchmarking
  • Table 96 Mckesson Corporation: Strategic Outlook
  • Table 97 Medipal Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Medipal Holdings Corporation: Service Benchmarking
  • Table 99 Mutual Drug: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Mutual Drug: Service Benchmarking
  • Table 101 Petrone Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Petrone Group: Service Benchmarking
  • Table 103 Petrone Group: Strategic Outlook
  • Table 104 Prodigy Health LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Prodigy Health LLC: Service Benchmarking
  • Table 106 Sinopharm Group Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Sinopharm Group Co. Ltd.: Service Benchmarking
  • Table 108 Smith Drug Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Smith Drug Co., Inc.: Service Benchmarking
  • Table 110 Walgreens Boots Alliance, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Walgreens Boots Alliance, Inc.: Service Benchmarking
  • Table 112 Walgreens Boots Alliance, Inc.: Strategic Outlook

List of Figures

  • Figure 1 Pharma Wholesale and Distribution Market Segmentation
  • Figure 2 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
  • Figure 3 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
  • Figure 4 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
  • Figure 5 Pharma Wholesale and Distribution Market Attractiveness Index by Region
  • Figure 6 Pharma Wholesale and Distribution Market: Market Dynamics
  • Figure 7 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 8 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 9 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 10 Short Term & Long-Term Planning
  • Figure 11 Impact of U.S. and China Trade War
  • Figure 12 Most Impacted Countries
  • Figure 13 Pharma Wholesale and Distribution Market: Porter's Five Forces Analysis
  • Figure 14 Pharma Wholesale and Distribution Market: PEST Analysis
  • Figure 15 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
  • Figure 16 Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 17 Pharma Wholesale and Distribution Market Share Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 18 Wholesalers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 19 Wholesalers Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 20 Wholesalers Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 21 Distributor Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 22 Distributor Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 23 Distributors Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 24 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
  • Figure 25 Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 26 Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025, 2030, 2035 (%)
  • Figure 27 Ethical/Branded Pharma Products Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 28 Ethical/Branded Pharma Products Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 29 Generic Pharma Products Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 30 Generic Pharma Products Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 31 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 32 Propaganda Cum Distribution (PCD) Franchise Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 33 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 34 OTC/Institutional Supply Pharma Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 35 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 36 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 37 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
  • Figure 38 Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 39 Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025, 2030, 2035 (%)
  • Figure 40 Branded Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 41 Branded Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 42 Generic Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 43 Generic Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 44 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 45 Over-the-counter (OTC) Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 46 Medical Devices Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 47 Medical Devices Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 48 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 49 Vaccines Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 50 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 51 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 52 Pharma Wholesale and Distribution Market by End-users: Market Attractiveness Index
  • Figure 53 Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 54 Pharma Wholesale and Distribution Market Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 55 Hospitals and Clinics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 56 Hospitals and Clinics Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 57 Retail Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 58 Retail Pharmacies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 59 Online / E-Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 60 Online / E-Pharmacies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 61 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 62 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 63 Pharma Wholesale and Distribution Market Forecast by Region 2025 and 2035, (Revenue, CAGR%)
  • Figure 64 Pharma Wholesale and Distribution Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 65 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 66 North America Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 67 North America Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 68 North America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 69 North America Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 70 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 71 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 72 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 73 North America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 74 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 75 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 76 North America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 77 North America Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 78 U.S. Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 79 Canada Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 80 Europe Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 81 Europe Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 82 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 83 Europe Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 84 Europe Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 85 Europe Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 86 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 87 Europe Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 88 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR.%)
  • Figure 89 Europe Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 90 Europe Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 91 Europe Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 92 Germany Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 93 France Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 94 UK Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 95 Italy Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 96 Spain Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 97 Russia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 98 Rest of Europe Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 99 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 100 Asia Pacific Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 101 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 102 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 103 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 104 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2035 (%)
  • Figure 105 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, .2025-2035 (US$ Billion, AGR %)
  • Figure 106 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Distribution .Type, 2025 & 2035 (%)
  • Figure 107 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, .2025-2035 (US$ Billion, AGR %)
  • Figure 108 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Product .Type, 2025 & 2035 (%)
  • Figure 109 Asia Pacific Pharma Wholesale and Distribution Market Forecast by End-users, .2025-2035 (US$ Billion, AGR %)
  • Figure 110 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 111 Japan Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 112 China Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 113 India Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 114 Australia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 115 South Korea Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 116 South-East Asia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 117 Rest of Asia Pacific Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 118 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 119 Latin America Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 120 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 121 Latin America Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 122 Latin America Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 123 Latin America Pharma Wholesale and Distribution Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 124 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 125 Latin America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 126 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, (US$ Billion, AGR %)
  • Figure 127 Latin America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 128 Latin America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 129 Latin America Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 130 Brazil Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 131 Mexico Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 132 Argentina Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 133 Colombia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 134 Rest of Latin America Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 135 MEA Pharma Wholesale and Distribution Market Attractiveness Index
  • Figure 136 MEA Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 137 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 138 MEA Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 139 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 140 MEA Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
  • Figure 141 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 142 MEA Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
  • Figure 143 MEA Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 144 MEA Pharma Wholesale and Distribution Market Share Forecast by Type, 2025 & 2035 (%)
  • Figure 145 MEA Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 146 MEA Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
  • Figure 147 GCC Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 148 South Africa Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 149 Rest of MEA Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 150 Cencora, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 151 Cencora, Inc.: Regional Market Shares, 2024
  • Figure 152 Cardinal Health, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 153 Cardinal Health, Inc.: Regional Market Shares, 2024
  • Figure 154 Mckesson Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
  • Figure 155 Mckesson Corporation: Regional Market Shares, 2024
  • Figure 156 Medipal Holdings Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 157 Sinopharm Group Co. Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR %)
  • Figure 158 Walgreens Boots Alliance, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)